Bevatas 300mg Injection

About

Bevatas 300mg Injection is a targeted biological therapy used in the treatment of various advanced cancers. It functions as an anti-angiogenic agent, meaning it works by inhibiting the formation of new blood vessels that tumors need to grow and spread. The active ingredient typically targets vascular endothelial growth factor (VEGF), a protein that plays a crucial role in angiogenesis. By blocking VEGF, Bevatas starves the tumor of nutrients and oxygen, thereby slowing its growth and progression. This medication is often used in combination with standard chemotherapy regimens for specific types of metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and ovarian cancer. It is administered intravenously by a healthcare professional in a clinical setting. Close monitoring for potential side effects, particularly those related to bleeding, blood clots, and hypertension, is essential throughout the treatment course to ensure patient safety and optimize therapeutic outcomes.

Uses

• Treatment of metastatic colorectal cancer.
• Management of non-small cell lung cancer.
• Therapy for glioblastoma multiforme.
• Used in advanced renal cell carcinoma.

Directions For Use

Bevatas 300mg Injection is administered intravenously by a qualified healthcare professional in a hospital or clinic setting. The dosage and infusion schedule are determined by your doctor.

Benefits

• Inhibits tumor angiogenesis.
• Slows cancer progression.
• Improves progression-free survival.
• Enhances efficacy of chemotherapy.
• Reduces tumor blood supply.
• Targets specific growth factors.

Side Effects

• Hypertension (high blood pressure)
• Proteinuria (protein in urine)
• Bleeding events (e.g., epistaxis)
• Thromboembolic events (blood clots)
• Fatigue and weakness
• Headache
• Diarrhea or constipation
• Nausea and vomiting
• Abdominal pain
• Wound healing complications
• Gastrointestinal perforation (rare)
• Allergic reactions

Safety Measures

• Alcohol - No specific interaction with alcohol, but it's generally advisable to limit intake during cancer treatment.
• Pregnancy - Bevatas is contraindicated during pregnancy due to severe potential harm to the fetus. Effective contraception is mandatory for women of childbearing potential.
• Breastfeeding - Breastfeeding is not recommended during treatment with Bevatas and for a period after, as the drug may be excreted in breast milk.
• Liver - Use with caution in patients with severe hepatic impairment; liver function should be monitored, though dose adjustments are not typically specified.
• Kidney - Monitor for proteinuria and kidney function; use with caution in patients with pre-existing renal conditions.
• Lung - Use with caution in patients with a history of hemoptysis or lung hemorrhage; monitor for new respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.